Delivery Order SPE2DB20D1100-SPE2DB25FB4U0

Award Date 4/1/25
Potential Completion Date 4/22/25
Potential Value $9.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,910.95 firm-fixed-price contract covers the supply of LENVIMA 10 MG DAILY DOSE 30S, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product. It is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the provision of LENVIMA 14 MG DAILY DOSE 60S, a pharmaceutical product. The contract is a firm-fixed-price delivery order contract with a period of performance through March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the delivery of LENVIMA 14 MG DAILY DOSE 60S, a pharmaceutical product, and has an ultimate completion date of March 11, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,910.95, is for the supply of Lenvima 14 mg daily dose 60-count medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $9,579.86 delivery order contract to AmerisourceBergen Drug Corp, Corporate Office Division, to provide 4565778797 LENVIMA 14 MG DAILY DOSE 60S pharmaceutical products. This order is not set aside and has an ultimate completion date of October 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,821.90, is for the delivery of the prescription drug LENVIMA 24 MG DAILY DOSE 90S. The contract has a period of performance through April 8, 2025 and utilizes a firm fixed price pricing arrangement. The contract was not designated as a set-aside. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) Delivery Order, with an ultimate completion date of April 11, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product. The contract has a ceiling value of $9,910.95 and a completion date of April 22, 2025. It is a firm-fixed-price contract type. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a Delivery Order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,279.78, is for the supply of LENVIMA 14 MG DAILY DOSE 60S, a specialty medication. This Delivery Order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB4U0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the pharmaceutical product LENVIMA 10 MG DAILY DOSE 30S. The contract has a total ceiling value of $9,910.95 and a period of performance through April 22, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/1/25, 7:59 AM